Display options
Share it on

Int J Endocrinol Metab. 2017 Mar 09;15(2):e42649. doi: 10.5812/ijem.42649. eCollection 2017 Apr.

Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.

International journal of endocrinology and metabolism

Arash Ordookhani, Kenneth D Burman

Affiliations

  1. Endocrine Section, Department of Internal Medicine, Providence Hospital, Washington, DC, 20017.
  2. Endocrine Section, MedStar Washington Hospital Center, Washington, DC, 20010.

PMID: 29026409 PMCID: PMC5626118 DOI: 10.5812/ijem.42649

Abstract

CONTEXT: There are contradictory results on the effect of hypothyroidism on the changes in hemostasis. Inadequate population-based studies limited their clinical implications, mainly on the risk of venous thromboembolism (VTE). This paper reviews the studies on laboratory and population-based findings regarding hemostatic changes and risk of VTE in hypothyroidism and autoimmune thyroid disorders.

EVIDENCE ACQUISITION: A comprehensive literature search was conducted employing MEDLINE database. The following words were used for the search: Hypothyroidism; thyroiditis, autoimmune; blood coagulation factors; blood coagulation tests; hemostasis, blood coagulation disorders; thyroid hormones; myxedema; venous thromboembolism; fibrinolysis, receptors thyroid hormone. The papers that were related to hypothyroidism and autoimmune thyroid disorder and hemostasis are used in this review.

RESULTS: Overt hypothyroidism is more associated with a hypocoagulable state. Decreased platelet count, aggregation and agglutination, von Willebrand factor antigen and activity, several coagulation factors such as factor VIII, IX, XI, VII, and plasminogen activator-1 are detected in overt hypothyrodism. Increased fibrinogen has been detected in subclinical hypothyroidism and autoimmune thyroid disease rendering a tendency towards a hypercoagulability state. Increased factor VII and its activity, and plasminogen activator inhibitor-1 are among several findings contributing to a prothrombotic state in subclinical hypothyroidism.

CONCLUSIONS: Overt hypothyroidism is associated with a hypocoagulable state and subclinical hypothyroidism and autoimmune thyroid disorders may induce a prothrombotic state. However, there are contradictory findings for the abovementioned thyroid disorders. Prospective studies on the risk of VTE in various levels of hypofunctioning of the thyroid and autoimmune thyroid disorders are warranted.

Keywords: Blood Coagulation Factors; Fibrinolysis; Hashimoto Disease; Hypothyroidism; Myxedema; Thyroiditis, Autoimmune; Venous Thromboembolism

Conflict of interest statement

Conflict of Interest:None to declare.

References

  1. Vascul Pharmacol. 2010 Mar-Apr;52(3-4):151-6 - PubMed
  2. J Clin Endocrinol Metab. 2007 Jul;92(7):2415-20 - PubMed
  3. Eur J Endocrinol. 2004 Feb;150(2):125-31 - PubMed
  4. Endocr J. 2007 Feb;54(1):45-52 - PubMed
  5. Blood. 2008 Jan 15;111(2):643-50 - PubMed
  6. Int J Clin Pract. 2006 Jun;60(6):655-9 - PubMed
  7. Eur J Endocrinol. 2011 Apr;164(4):599-603 - PubMed
  8. Horm Metab Res. 1991 Dec;23(12):609-11 - PubMed
  9. Endocrine. 2006 Aug;30(1):63-7 - PubMed
  10. Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):221-6 - PubMed
  11. Scand J Clin Lab Invest. 1964;16:511-2 - PubMed
  12. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1776-85 - PubMed
  13. Ann Intern Med. 2008 Jun 3;148(11):832-45 - PubMed
  14. Semin Thromb Hemost. 2011 Feb;37(1):35-40 - PubMed
  15. Semin Thromb Hemost. 2007 Nov;33(8):798-809 - PubMed
  16. BMC Med. 2011 Jan 10;9:1 - PubMed
  17. J Thromb Thrombolysis. 2010 Jan;29(1):87-91 - PubMed
  18. Thyroid. 2007 Nov;17(11):1075-84 - PubMed
  19. Blood Coagul Fibrinolysis. 2015 Apr;26(3):282-4 - PubMed
  20. Biomed Pharmacother. 2005 Jan-Feb;59(1-2):8-14 - PubMed
  21. Thromb Res. 2010 Jul;126(1):e61-2 - PubMed
  22. Endocrine. 2009 Feb;35(1):75-80 - PubMed
  23. Thromb Haemost. 2007 May;97(5):803-6 - PubMed
  24. Ann Intern Med. 1982 Nov;97(5):713-6 - PubMed
  25. Thromb Haemost. 1987 Dec 18;58(4):964-5 - PubMed
  26. J Endocrinol Invest. 2002 Apr;25(4):345-50 - PubMed
  27. Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9 - PubMed
  28. J Thromb Haemost. 2006 Sep;4(9):1886-90 - PubMed
  29. J Endocrinol Invest. 1988 Nov;11(10):723-5 - PubMed
  30. Biol Rev Camb Philos Soc. 2000 Nov;75(4):519-631 - PubMed
  31. Diabetes Res Clin Pract. 2006 Aug;73(2):150-7 - PubMed
  32. Int Immunopharmacol. 2008 Dec 20;8(13-14):1863-5 - PubMed
  33. J Clin Endocrinol Metab. 2007 Aug;92(8):3006-12 - PubMed
  34. Lancet. 2012 Jan 21;379(9812):244-9 - PubMed
  35. J Clin Endocrinol Metab. 2001 Feb;86(2):732-7 - PubMed
  36. Thromb Res. 1991 Dec 15;64(6):745-9 - PubMed
  37. Acta Haematol. 1978;59(3):171-7 - PubMed
  38. Br Med J. 1967 Oct 28;4(5572):147-8 - PubMed
  39. N Engl J Med. 2008 Aug 28;359(9):938-49 - PubMed
  40. Hematology. 2006 Jun;11(3):203-8 - PubMed
  41. J Clin Endocrinol Metab. 2002 Feb;87(2):489-99 - PubMed
  42. Thromb Haemost. 2006 Apr;95(4):750-1 - PubMed
  43. JAMA. 2000 Apr 19;283(15):2008-12 - PubMed
  44. Thromb Res. 2003 Jun 1;110(4):243-7 - PubMed
  45. Br Med J. 1965 Mar 13;1(5436):686-8 - PubMed
  46. J Lab Clin Med. 1987 Nov;110(5):576-82 - PubMed
  47. Semin Thromb Hemost. 2009 Apr;35(3):288-94 - PubMed
  48. J Clin Endocrinol Metab. 2004 Sep;89(9):4469-73 - PubMed
  49. Endocr J. 2005 Jun;52(3):363-7 - PubMed
  50. Haemophilia. 2014 May;20(3):326-32 - PubMed
  51. Lancet. 1987 May 2;1(8540):1007-9 - PubMed
  52. Recent Pat Endocr Metab Immune Drug Discov. 2011 Jan;5(1):50-7 - PubMed
  53. Thromb Haemost. 2013 Feb;109(2):214-20 - PubMed
  54. J Clin Endocrinol Metab. 2006 Feb;91(2):530-4 - PubMed
  55. Ann Intern Med. 1997 Apr 15;126(8):638-44 - PubMed
  56. Clin Appl Thromb Hemost. 2006 Jul;12(3):364-8 - PubMed
  57. Saudi Med J. 2008 Sep;29(9):1289-93 - PubMed
  58. J Endocrinol Invest. 2004 Dec;27(11):1065-71 - PubMed
  59. J Endocrinol Invest. 2004 Oct;27(9):886-92 - PubMed
  60. Blood Coagul Fibrinolysis. 1999 Dec;10(8):481-6 - PubMed
  61. Clin Appl Thromb Hemost. 2010 Feb;16(1):107-9 - PubMed
  62. Endocr Rev. 2008 Feb;29(1):76-131 - PubMed
  63. Acta Endocrinol (Copenh). 1992 May;126(5):399-403 - PubMed
  64. Br J Haematol. 2005 May;129(3):307-21 - PubMed
  65. Thromb Haemost. 1976 Jun 30;35(3):607-19 - PubMed
  66. Eur J Endocrinol. 2005 Mar;152(3):355-61 - PubMed
  67. Thromb Haemost. 1998 Jan;79(1):99-103 - PubMed
  68. J Thromb Haemost. 2006 Sep;4(9):1882-5 - PubMed
  69. Eur J Endocrinol. 2008 Aug;159(2):145-52 - PubMed
  70. Thyroid. 2011 Aug;21(8):837-43 - PubMed
  71. Acta Haematol. 1985;74(1):58-9 - PubMed
  72. Thromb Haemost. 1992 Jun 1;67(6):729 - PubMed
  73. Med Hypotheses. 2011 Jun;76(6):855-7 - PubMed
  74. Clin Appl Thromb Hemost. 2010 Oct;16(5):568-73 - PubMed
  75. Thromb Res. 2012 Apr;129(4):520-2 - PubMed
  76. Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):375-81 - PubMed
  77. Exp Clin Endocrinol Diabetes. 2010 Jun;118(6):381-7 - PubMed
  78. Clin Appl Thromb Hemost. 2009 Dec;15(6):676-80 - PubMed
  79. Thyroid. 2003 Oct;13(10):971-7 - PubMed
  80. J Thromb Haemost. 2012 Aug;10(8):1708-10 - PubMed
  81. Postgrad Med J. 1990 Apr;66(774):280-4 - PubMed
  82. Endocrinology. 2004 Jun;145(6):2804-14 - PubMed
  83. Eur J Clin Invest. 2001 Feb;31(2):131-7 - PubMed
  84. Endocrine. 2014 Aug;46(3):651-8 - PubMed
  85. Eur J Endocrinol. 1997 Jan;136(1):1-7 - PubMed
  86. Semin Thromb Hemost. 2011 Feb;37(1):7-10 - PubMed
  87. Int J Clin Pract. 2003 Mar;57(2):78-81 - PubMed
  88. Neurology. 2014 May 6;82(18):1643-52 - PubMed
  89. Endocrine. 2009 Aug;36(1):110-8 - PubMed
  90. Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S176-7 - PubMed
  91. J Neurol. 2008 Jul;255(7):962-6 - PubMed
  92. Clin Endocrinol (Oxf). 2004 Aug;61(2):232-8 - PubMed
  93. Intern Med. 2009;48(5):281-5 - PubMed
  94. J Clin Res Pediatr Endocrinol. 2012 Sep;4(3):146-50 - PubMed
  95. Thromb Haemost. 1976 Apr 30;35(2):415-22 - PubMed
  96. N Engl J Med. 1965 Nov 11;273(20):1057-61 - PubMed
  97. Stroke. 2005 Oct;36(10):2302-10 - PubMed

Publication Types